Dr. Aadel Ahmed Chaudhuri, MD

Dr. Chaudhuri practices at BJC Northwest Healthcare in Florissant, Missouri.

Dr. Chaudhuri's NPI, 1487097572, was assigned on April 9, 2013. Dr. Chaudhuri graduated from Stanford University School of Medicine in 2013. Dr. Chaudhuri holds Minnesota license 76210.

Dr. Chaudhuri's primary practice is BJC Northwest Healthcare, at 1225 Graham Rd, Florissant, MO 63031 in Saint Louis County. The practice phone is (314) 653-5000.

Dr. Chaudhuri's primary practice is BJC Northwest Healthcare in Florissant, Missouri. Dr. Chaudhuri is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is WashU Medicine Physicians. Dmand AI also links Dr. Chaudhuri to 1 more group practice or clinic, 1 hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chaudhuri practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Chaudhuri's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Chaudhuri's licenses on file in 2 states: Minnesota and Missouri.

CMS data shows 115 Medicare services from Dr. Chaudhuri across 4 procedure codes in 2024, for 43 Medicare patients. Medicare paid $4,711 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 43 Medicare patients who saw Dr. Chaudhuri in 2024. The largest group is 65 to 74, with 25 patients. 74% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chaudhuri's median patient age at 68, with 54% women.

In 2021, Dr. Chaudhuri wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $426 in total drug cost. In 2020, CMS named 14 claims across 1 drug.

Dr. Chaudhuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 88 papers to Dr. Chaudhuri, published from 2011 to 2025. 2023 was the busiest year, with 10. The most frequent topics are Biomarkers, Tumor, Lung Neoplasms and Carcinoma, Non-Small-Cell Lung. Dr. Chaudhuri has published most often in Clin Cancer Res. Dr. Chaudhuri's most frequent co-authors are Maximilian Diehn, MD, PhD, Billy W. Loo, MD, PhD and Heather Ann Wakelee, MD.

Dmand AI links Dr. Chaudhuri to 10 clinical trials, 2 of them phase 1 studies. 5 are still active or recruiting. Conditions studied include Esophageal Neoplasms, Carcinoma, Non-Small-Cell Lung and Chondrosarcoma. Washington University School of Medicine sponsors the most, 10.

CMS Open Payments shows 44 general payments to Dr. Chaudhuri from 18 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Roche Sequencing Solutions, Inc. paid the most, $13,244.

Dr. Chaudhuri graduated from Stanford University School of Medicine in 2013.